Literature DB >> 2841893

CDC definitions for nosocomial infections, 1988.

J S Garner1, W R Jarvis, T G Emori, T C Horan, J M Hughes.   

Abstract

The Centers for Disease Control (CDC) has developed a new set of definitions for surveillance of nosocomial infections. The new definitions combine specific clinical findings with results of laboratory and other tests that include recent advances in diagnostic technology; they are formulated as algorithms. For certain infections in which the clinical or laboratory manifestations are different in neonates and infants than in older persons, specific criteria are included. The definitions include criteria for common nosocomial infections as well as infections that occur infrequently but have serious consequences. The definitions were introduced into hospitals participating in the CDC National Nosocomial Infections Surveillance System (NNIS) in 1987 and were modified based on comments from infection control personnel in NNIS hospitals and others involved in surveillance, prevention, and control of nosocomial infections. The definitions were implemented for surveillance of nosocomial infections in NNIS hospitals in January 1988 and are the current CDC definitions for nosocomial infections. Other hospitals may wish to adopt or modify them for use in their nosocomial infections surveillance programs.

Entities:  

Mesh:

Year:  1988        PMID: 2841893     DOI: 10.1016/0196-6553(88)90053-3

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  1113 in total

1.  Development of a Web-based clinical information system for surveillance of multiresistant organisms and nosocomial infections.

Authors:  S Bouam; E Girou; C Brun-Buisson; E Lepage
Journal:  Proc AMIA Symp       Date:  1999

2.  Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam.

Authors:  Y Carmeli; J Castro; G M Eliopoulos; M H Samore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

3.  Validity of earlier positivity of central venous blood cultures in comparison with peripheral blood cultures for diagnosing catheter-related bacteremia in cancer patients.

Authors:  V B Malgrange; M C Escande; S Theobald
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Silver catheter study: methods and results of microbiological investigations.

Authors:  C Schoerner; J P Guggenbichler; S Lugauer; A Regenfus
Journal:  Infection       Date:  1999       Impact factor: 3.553

5.  Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.

Authors:  R Pantophlet; H Seifert; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 6.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

7.  Pseudoepidemic of Aspergillus niger infections traced to specimen contamination in the microbiology laboratory.

Authors:  V L Laurel; P A Meier; A Astorga; D Dolan; R Brockett; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Authors:  C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia.

Authors:  G R Nimmo; J Schooneveldt; G O'Kane; B McCall; A Vickery
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

10.  Concerns about 99mTc-labelled ciprofloxacin for infection detection.

Authors:  K E Britton; D W Wareham; S S Das
Journal:  Eur J Nucl Med       Date:  2001-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.